Clinical Validation of a Blood-Based Predictive Test for Stratification of Response to Tumor Necrosis Factor Inhibitor Therapies in Rheumatoid Arthritis PatientsTheodore Mellors, Viatcheslav R. Akmaev, Susan Dina Ghiassian et al.|Network and Systems Medicine|2020Cited by 42
A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational StudyStanley Cohen, Viatcheslav R. Akmaev, Alvin F. Wells et al.|Rheumatology and Therapy|2021Cited by 34
Network-based response module comprised of gene expression biomarkers predicts response to infliximab at treatment initiation in ulcerative colitisSusan Dina Ghiassian, Viatcheslav R. Akmaev, Ivan Voitalov et al.|Translational research|2022Cited by 8
The module triad: a novel network biology approach to utilize patients’ multi-omics data for target discovery in ulcerative colitisIvan Voitalov, Susan Dina Ghiassian, Lixia Zhang et al.|Scientific Reports|2022Cited by 7
A systems-based method to repurpose marketed therapeutics for antiviral use: a SARS-CoV-2 case studyMengran Wang, Susan Dina Ghiassian, Johanna B. Withers et al.|Life Science Alliance|2021Cited by 4